Rare Disease and Orphan Drugs Journal
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Rare Disease and Orphan Drugs Journal
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig5

From:  Longitudinal biomarker evaluation in Fabry disease patients receiving lentivirus-mediated gene therapy
Longitudinal biomarker evaluation in Fabry disease patients receiving lentivirus-mediated gene therapy

Figure 5. Longitudinal biomarker follow-up of Fabry gene therapy trial participant #2.

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/rare-disease-and-orphan-drugs-journal

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/rare-disease-and-orphan-drugs-journal

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2025 OAE Publishing Inc., except certain content provided by third parties